Resurfacing a December report: Agilus says preventive testing grew 30% in 2025 as precision diagnostics gain traction
In a December 2025 disclosure resurfacing now, Agilus Diagnostics reported 30% year-on-year growth in preventive health testing in 2025, while lifestyle and gut-health test volumes rose 47% year to date, signalling increasing consumer demand for proactive and specialised diagnostics.
The development
Agilus Diagnostics reported preventive health testing grew 30 per cent year-on-year (Y-O-Y) in 2025, while lifestyle and gut health testing volumes rose 47 per cent year-to-date.
The numbers
- 30 per cent
- 2025
- 47 per cent
- 31 per cent
- 16 per cent
Why it matters to operators and investors
The 30% rise in preventive testing and 47% growth in specialised test volumes suggest a favourable mix shift toward higher-value diagnostics, supporting growth potential if demand remains durable.
What to watch next
- Quarterly preventive-testing revenue growth versus test-volume growth and average realization per patient.
- Repeat-test rates, subscription or annual-plan adoption, and share of orders from direct-to-consumer channels.
- Contribution of lifestyle and gut-health panels to revenue, gross margin and customer acquisition costs.
- New insurer reimbursement, employer wellness contracts or preventive-screening policy initiatives.
- Discount intensity and specialty-test launches from major diagnostic chains, digital-health platforms and hospitals.
The counter-case
The reported growth may reflect a low base, promotional campaigns, expanded test menus or channel distribution rather than a durable shift in consumer behaviour. Preventive, lifestyle and gut-health panels are often discretionary and vulnerable to household-budget pressure; high volumes do not necessarily translate into repeat testing, attractive margins or clinical utility. The 47% year-to-date figure is also not directly comparable with full-year growth and may be influenced by seasonality.